Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Challenging the Association of Marijuana Laws With Teen Marijuana Use

Challenging the Association of Marijuana Laws With Teen Marijuana Use Letters Mirzakhani et al state that data suggest the safety of LDA Antonis Voutetakis, MD, PhD treatment based on the Etude EPIdémiologique sur les Petits Panagiota Pervanidou, MD, PhD Ages Gestationnels (EPIPAGE) study, a significant observa- Christina Kanaka-Gantenbein, MD, PhD tional study that recruited participants more than 20 years ago Author Affiliations: First Department of Pediatrics, School of Medicine, and obtained medical information retrospectively. There- National and Kapodistrian University of Athens, Athens, Greece. fore, important limitations with respect to the study’s evalu- Corresponding Author: Antonis Voutetakis, MD, PhD, First Department of ation of LDA treatment exist: nonrandomization (reflected in Pediatrics, School of Medicine, National and Kapodistrian University of Athens, significant differences between the aspirin-treated and non- Thivon 1, Athens, 11527, Greece (voutetakis@yahoo.com). treated group), the rate of loss to follow-up (significantly higher Published Online: November 4, 2019. doi:10.1001/jamapediatrics.2019 in the no-LDA group compared with the LDA group; 27% vs .4021 16%), and inability to control or follow actual dosing and com- Conflict of Interest Disclosures: None reported. pliance. Notably, the study focused in neonates born very pre- 1. Voutetakis A, Pervanidou P, Kanaka-Gantenbein C. Aspirin for the prevention of preeclampsia and potential consequences for fetal brain development. JAMA term http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

Challenging the Association of Marijuana Laws With Teen Marijuana Use

JAMA Pediatrics , Volume 174 (1) – Jan 11, 2020

Loading next page...
 
/lp/american-medical-association/challenging-the-association-of-marijuana-laws-with-teen-marijuana-use-GrCdVNRHnW

References (1)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2019.4229
Publisher site
See Article on Publisher Site

Abstract

Letters Mirzakhani et al state that data suggest the safety of LDA Antonis Voutetakis, MD, PhD treatment based on the Etude EPIdémiologique sur les Petits Panagiota Pervanidou, MD, PhD Ages Gestationnels (EPIPAGE) study, a significant observa- Christina Kanaka-Gantenbein, MD, PhD tional study that recruited participants more than 20 years ago Author Affiliations: First Department of Pediatrics, School of Medicine, and obtained medical information retrospectively. There- National and Kapodistrian University of Athens, Athens, Greece. fore, important limitations with respect to the study’s evalu- Corresponding Author: Antonis Voutetakis, MD, PhD, First Department of ation of LDA treatment exist: nonrandomization (reflected in Pediatrics, School of Medicine, National and Kapodistrian University of Athens, significant differences between the aspirin-treated and non- Thivon 1, Athens, 11527, Greece (voutetakis@yahoo.com). treated group), the rate of loss to follow-up (significantly higher Published Online: November 4, 2019. doi:10.1001/jamapediatrics.2019 in the no-LDA group compared with the LDA group; 27% vs .4021 16%), and inability to control or follow actual dosing and com- Conflict of Interest Disclosures: None reported. pliance. Notably, the study focused in neonates born very pre- 1. Voutetakis A, Pervanidou P, Kanaka-Gantenbein C. Aspirin for the prevention of preeclampsia and potential consequences for fetal brain development. JAMA term

Journal

JAMA PediatricsAmerican Medical Association

Published: Jan 11, 2020

There are no references for this article.